Cundy Kenneth C 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Jun 7, 2022
Insider Transaction Report
Form 4
Cundy Kenneth C
Chief Scientific Officer
Transactions
- Award
Option to purchase Common Stock
2022-06-01+350,169→ 350,169 totalExercise: $2.91From: 2022-07-01Exp: 2027-06-30→ Common Stock (350,169 underlying)
Footnotes (1)
- [F1]Mr. Cundy received a stock option to purchase shares of the Issuer's common stock pursuant to the Issuer's 2020 Stock Incentive Plan: (a) 233,446 shares will vest in equal quarterly installments from July 1, 2022 through April 1, 2026. (b) 116,723 shares will vest upon completion of certain milestone events.